Stephen Garbacz
About Stephen Garbacz
Stephen Garbacz serves as the Senior Vice President of Finance and Corporate Controller at Tessera Therapeutics, where he has worked since 2021. With extensive experience in finance across various sectors, he has held significant roles at companies such as Anika Therapeutics and Biogen Idec.
Work at Tessera Therapeutics
Stephen Garbacz has served as the Senior Vice President of Finance and Corporate Controller at Tessera Therapeutics since 2021. In this role, he oversees financial operations and corporate governance for the company, which is based in Cambridge, Massachusetts. His responsibilities include managing financial strategies and ensuring compliance with regulatory requirements, which are critical for the company's growth in the life sciences sector.
Previous Experience in Finance
Before joining Tessera Therapeutics, Stephen Garbacz held the position of Vice President of Finance and Corporate Controller at Anika Therapeutics from 2019 to 2021. Prior to that, he was the Senior Vice President of Finance and Operations at Spero Therapeutics from 2015 to 2019. His extensive background includes various roles at Biogen Idec, where he served as Controller for International operations and Finance Director for Corporate Accounting.
Education and Expertise
Stephen Garbacz earned his MBA in Finance from NYU Stern School of Business, where he studied from 1984 to 1986. He also holds a Bachelor of Science degree in Economics from George Mason University, completed between 1978 and 1981. His academic background supports his expertise in capital creation and IPO processes, which are vital for early-stage life sciences companies.
Background in International Business
Stephen Garbacz has a strong background in international business operations, having worked in various global financial roles. His experience includes serving as Controller - International at Biogen Idec in Switzerland and as Director of International Treasury at Kraft Foods. This international exposure enhances his ability to manage financial strategies effectively at Tessera Therapeutics.
Experience in Biotech and High-Tech Industries
Stephen Garbacz has significant experience in the biotech, medical devices, and high-tech industries. His roles in these sectors have equipped him with a diverse perspective on financial management, particularly in innovative environments. He possesses substantial expertise in mergers and acquisitions, licensing, and divestitures, which are essential for strategic growth in the biotech industry.